Next Generation Cancer Diagnostic Devices Market Report Analysis, Research Studies | GE Healthcare, Siemens Healthineers & Philips Healthcare.

The Next Generation Cancer Diagnostic Devices Market is projected to grow at a robust CAGR of 18% from 2024 to 2031.

Cancer diagnostics involves detecting various biomarkers, proteins, and specific symptoms to identify cancerous tumors in patients. This process relies heavily on advanced technologies and devices specifically designed for cancer diagnosis. Cancer diagnostic devices are primarily categorized into genomics, proteomics, metabolomics, epigenetics, instrument-based methods, and tumor biomarker tests. According to the National Cancer Institute, approximately 2 million cancer cases were diagnosed in the United States in 2018, with nearly 609,640 projected deaths due to cancer.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/next-generation-cancer-diagnostic-devices-market

Market Dynamics:

The increasing incidence of cancer cases is expected to drive the global next-generation cancer diagnostic device market during the forecast period.

According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with over 18.1 million cases diagnosed in 2018. The most common cancers in the U.S. include lung, breast, prostate, colorectal, thyroid, pancreatic cancer, non-Hodgkin lymphoma, melanoma, renal pelvis cancer, kidney cancer, and leukemia. In 2020, approximately 19 million new cancer cases were diagnosed worldwide, according to WHO, while the American Cancer Society reported 89,500 new cases in the U.S. This surge has driven the adoption of cancer diagnostic devices.

The number of advanced research projects in oncology and preventive diagnosis is expected to boost the global next-generation cancer diagnostic market. Advances in diagnostic imaging techniques have significantly increased the demand for cancer diagnostics. Imaging has become a crucial element of cancer detection, particularly for breast, lung, prostate, and colorectal cancers. For instance, in 2018, Toshiba Medical Systems Corporation introduced MicroPure ultrasound technology for early detection of microcalcification in breast tissue. Additionally, evolving PET camera technology and the integration of PET/CT have enhanced diagnostic accuracy by providing simultaneous morphological and functional information, further driving market growth.

Market Segmentation:

By Test Type: Liquid Biopsy, Imaging Tests, Tumour Biomarkers Tests, Insitu Hybridization, Immunohistochemistry, Others.

By Cancer Type: Lung Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Kidney Cancer, Others.

By End-user : Hospital associated labs, Cancer research institutes, Diagnostic imaging centres, Diagnostic laboratories.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/next-generation-cancer-diagnostic-devices-market

Competitive Landscape:

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Biocartis
• Becton
• Abbott laboratories
• Hoffman-La Roche AG
• Dickinson and Company
• Thermo Fischer Scientific
• Sysmex Corporation

Product Portfolio:

Company Overview: GE Healthcare is an American multinational conglomerate headquartered in Chicago, Illinois, and incorporated in New York. Since 2017, the company has been a leading manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals used in medical imaging procedures. GE Healthcare provides a wide range of imaging modalities, including advanced technologies in magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear medicine, positioning itself as a key player in the global healthcare sector.

Regional Analysis:

The global Next Generation Cancer Diagnostic Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Next Generation Cancer Diagnostic Devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

IVD quality control Market: https://datamintelligence.com/research-report/ivd-quality-control-market

Hydrocephalus Shunts Market: https://datamintelligence.com/research-report/hydrocephalus-shunts-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.